A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

NCT07753369 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Lymphocytic Lymppho
Relapsed/Refractory Chronic Lymphocytic Leukemia

Interventions

DRUG: TQB3909 Tablets
DRUG: Bendamustine Injection
DRUG: Rituximab injection
DRUG: Lenalidomide Capsules

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.